PDL BIOPHARMA INC's ticker is and the CUSIP is 69329Y954. A total of 3 filers reported holding PDL BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $268,000 | +2133.3% | 1,086 | +2615.0% | 0.00% | – |
| Q3 2020 | $12,000 | – | 40 | +700.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 5 | -58.3% | 0.00% | – |
| Q4 2019 | $3,000 | -25.0% | 12 | -40.0% | 0.00% | – |
| Q3 2019 | $4,000 | – | 20 | +900.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 2 | -77.8% | 0.00% | – |
| Q3 2018 | $2,000 | -96.1% | 9 | -95.9% | 0.00% | – |
| Q2 2018 | $51,000 | +1175.0% | 218 | +303.7% | 0.00% | – |
| Q1 2018 | $4,000 | – | 54 | +145.5% | 0.00% | – |
| Q4 2017 | $0 | – | 22 | -71.4% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 77 | -70.5% | 0.00% | – |
| Q2 2017 | $4,000 | -73.3% | 261 | -3.0% | 0.00% | -100.0% |
| Q1 2017 | $15,000 | +200.0% | 269 | +484.8% | 0.00% | – |
| Q4 2016 | $5,000 | -91.4% | 46 | -96.1% | 0.00% | -100.0% |
| Q3 2016 | $58,000 | +45.0% | 1,193 | +10.3% | 0.00% | +33.3% |
| Q2 2016 | $40,000 | +1233.3% | 1,082 | +2202.1% | 0.00% | – |
| Q1 2016 | $3,000 | +50.0% | 47 | +123.8% | 0.00% | – |
| Q4 2015 | $2,000 | -77.8% | 21 | -41.7% | 0.00% | -100.0% |
| Q3 2015 | $9,000 | -18.2% | 36 | -14.3% | 0.00% | 0.0% |
| Q1 2015 | $11,000 | 0.0% | 42 | -23.6% | 0.00% | 0.0% |
| Q4 2014 | $11,000 | – | 55 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 36 | $9,000 | 0.00% |
| Citadel Advisors | 20,000 | $101,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,100 | $6,000 | 0.00% |